Hepion Pharmaceuticals, Inc

(NASDAQ:HEPA)

Latest On Hepion Pharmaceuticals, Inc (HEPA):

Date/Time Type Description Signal Details
2023-05-26 11:48 ESTNewsWhy I Am Staying Away From Hepion PharmaceuticalsN/A
2023-05-22 08:14 ESTNewsHepion Pharma NASH candidate meets phase 2 goal; up 68%N/A
2023-01-11 10:46 ESTNewsHepion climbs 39% on pre-clinical data for lead assetN/A
2022-12-06 02:19 ESTNewsHepion granted 180-day extension by Nasdaq to meet bid price requirementsN/A
2022-11-04 20:43 ESTNewsHepion Pharmaceuticals dips after pricing $20M convertible preferred stock offeringN/A
2022-08-31 13:58 ESTNewsHepion Pharma rises as company begins NASH treatment trialN/A
2022-06-14 17:17 ESTNewsDr. Launa J. Aspeslet is the new chief of operations at Hepion PharmaceuticalsN/A
2022-05-03 14:40 ESTNewsHepion Pharma announces clinical collaboration with HepQuant for a phase 2b NASH trialN/A
2022-02-17 17:51 ESTNewsHepion Pharmaceuticals CEO Robert Foster - Dash To Beat NASHN/A
2022-01-26 22:27 ESTNewsHepion's rencofilstat combo reduces tumor growth in nonclinical liver cancer studyN/A
2022-01-22 03:43 ESTNewsHepion Pharmaceuticals: Facing The Momentous Year 2022N/A
2021-12-21 22:03 ESTNewsFDA clears Hepion Pharma's CRV431 application for liver cancerN/A
2021-12-01 02:27 ESTNewsHepion Pharmaceuticals gets FDA fast track designation for CRV431 to treat liver diseaseN/A
2021-11-16 21:39 ESTNewsHepion Pharma reports anti-cancer activity of CRV431 in a liver cancer study in miceN/A
2021-10-09 21:50 ESTNewsA look at the biopharmas developing new treatments for liver diseasesN/A
2021-09-29 16:19 ESTNewsEndpoints met in Hepion drug-drug interaction study of NASH candidate; shares up 6%N/A
2021-09-21 19:55 ESTNewsHepion buoyed by additional phase 2a data for NASH candidateN/A
2021-09-21 19:42 ESTNewsAdditional Phase IIa Data Confirms Hepion's CRV431 As A Very Promising NASH Candidate DrugN/A
2021-09-09 05:28 ESTNewsHepion Pharmaceuticals: A Promising Early-Stage Biopharma In The NASH RaceN/A
2021-07-21 11:04 ESTNewsTreating Chronic Liver Disease - Interview With Hepion Pharmaceuticals CEO Dr. Robert Foster (Video)N/A
2021-07-21 10:40 ESTNewsHepion shares fall after CRV431 mid-stage NASH study resultsN/A
2021-02-16 10:11 ESTNewsHepion Pharma plummets 26% on capital raiseN/A
2021-02-12 19:16 ESTNewsAttractive Risk-Reward Profile For Hepion PharmaceuticalsN/A
2021-02-12 19:15 ESTNewsHepion to raise capital in proposed public offeringN/A
2021-02-10 12:24 ESTNewsNew medical chief at Hepion Pharma, shares up 4%N/A
2020-12-29 17:13 ESTNewsHepion Pharma cleared to advance final dosing cohort in NASH trialN/A
2020-12-29 17:12 ESTNewsHepion pharmaceuticals announces positive data for NASH treatment CRV431N/A
2020-12-22 20:52 ESTNewsHepion Pharma to begin CRV431 testing in COVID-19 patientsN/A
2020-12-11 06:39 ESTNewsDosing underway in higher dose cohort with Hepion's CRV431 in NASH studyN/A
2020-12-02 23:43 ESTNewsHepion Pharma's lead drug can 'potentially' lower the risk of ischemic stroke, study showsN/A
2020-12-02 12:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $13 to $10.Neutral
2020-11-26 20:15 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 00:32 ESTNewsHepion Pharma prices equity offering at $1.50N/A
2020-11-18 20:03 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 11:56 ESTEarnings EstimateAn EPS average of -$0.24 is estimated for the quarter ending on March 31, 2021.Buy
2020-11-07 16:02 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 11:54 ESTFinancialsCompany financials have been released.Neutral
2020-10-06 12:54 ESTNewsHepion announces A.I. platform for drug developmentN/A
2020-09-26 12:58 ESTFinancialsCompany financials have been released.Neutral
2020-09-18 06:22 ESTNewsHepion's lead drug shows antiviral activity against COVID-19N/A
2020-09-17 05:06 ESTFinancialsCompany financials have been released.Neutral
2020-09-01 10:04 ESTNewsHepion Pharma completes final dosing in multiple ascending dose study of CRV431N/A
2020-08-15 16:53 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:03 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 16:56 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 20:56 ESTFinancialsCompany financials have been released.Neutral
2020-08-05 15:14 ESTNewsHepion rallies on start of mid-stage NASH studyN/A
2020-07-31 01:13 ESTFinancialsCompany financials have been released.Neutral
2020-07-24 04:49 ESTAnalyst RatingThe Analyst Target Price has increased from $10.5 to $13.Buy
2020-07-23 17:16 ESTFinancialsCompany financials have been released.Neutral

About Hepion Pharmaceuticals, Inc (HEPA):

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of pleiotropic drug therapy for the treatment of chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that has completed the Phase I clinical trials for multiple biochemical pathways involved in the progression of liver diseases; and Tenofovir exalidex, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of Hepatitis B. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.

HEPA Quotes by TradingView

See Advanced Chart

General

  • Name Hepion Pharmaceuticals, Inc
  • Symbol HEPA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 12
  • Last Split Factor1:70
  • Last Split Date2019-06-03
  • Fiscal Year EndDecember
  • IPO Date2014-02-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Web URLhttp://www.hepionpharma.com
View More

Valuation

  • Trailing PE 0.37
  • Price/Book (Most Recent Quarter) 12.84
  • Enterprise Value EBITDA 0.15
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.39
  • Return on Assets -53%
  • Return on Equity -119%
  • Earnings Per Share -$50.58
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 167.31 million
  • EBITDA -10443210
  • Analyst Target Price $10
  • Book Value Per Share $4.20
View More

Share Statistics

  • Shares Outstanding 76.23 million
  • Shares Float 7.41 million
  • % Held by Insiders 388%
  • % Held by Institutions 13.78%
  • Shares Short 2.6 million
  • Shares Short Prior Month 696465
  • Short Ratio 0.28
  • Short % of Float 3%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 1.32
  • 52 Week High $4.83
  • 52 Week Low $1.26
  • 50 Day Moving Average 2.24
  • 200 Day Moving Average 2.55
View More

Dividends

  • Dividend Date 2019-06-03
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Hepion Pharmaceuticals, Inc (HEPA) Dividend Calendar:

HEPA's last dividend payment was made to shareholders on June 3, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Hepion Pharmaceuticals, Inc (HEPA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-16$N/A-$0.69-$0.51-35.29%
2020-06-302020-08-12$N/A-$0.58-$0.50-16%
2020-03-312020-06-30$N/A-$0.97-$0.25-288%
2019-12-312020-02-26$N/A-$0.53-$0.9644.79%
2019-09-302019-11-14$N/A-$0.53-$0.6417.19%
2019-06-302019-08-14$N/A-$7.48
2019-03-312019-05-15$N/A-$8.03
2018-12-312019-03-14$N/A-$9.80-$25.9062.16%
2018-09-302018-11-14$N/A-$44.10-$25.90-70.27%
2018-06-302018-08-14$N/A-$26.60-$27.302.56%
2018-03-312018-05-15-$18.60
2017-12-312018-03-26-$11.20-$39.2071.43%
2017-09-302017-11-14-$44.80-$39.20-14.29%
2017-06-302017-09-28$33.60-$56.00160%
2017-03-312017-04-12-$67.20-$61.60-9.09%
2016-12-312017-02-14-$44.80-$67.2033.33%
2016-09-302016-11-14-$70.22-$84.0016.4%
2016-06-302016-09-28-$89.60-$89.600%
2016-03-312016-05-13-$78.40-$128.8039.13%
2015-12-312016-02-12-$61.60-$137.2055.1%
2015-09-302015-11-12-$0.22-$0.13-69.23%
2015-06-302015-09-25-$0.58-$0.20-190%
2015-03-312015-05-14-$0.20-$0.16-25%
2014-12-312015-02-12-$199.86
2014-09-302014-11-13-$40.74
2014-06-302014-09-29$132.77
2014-03-312014-03-31-$353.88

Hepion Pharmaceuticals, Inc (HEPA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Hepion Pharmaceuticals, Inc (HEPA) Chart:

Hepion Pharmaceuticals, Inc (HEPA) News:

Below you will find a list of latest news for Hepion Pharmaceuticals, Inc (HEPA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Hepion Pharmaceuticals, Inc (HEPA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest HEPA Trades:

Date Shares Price
Jun 13, 2022 2:29 PM EST6$0.6448
Jun 13, 2022 3:15 PM EST100$0.66
Jun 13, 2022 3:15 PM EST100$0.661
Jun 13, 2022 4:57 PM EST100$0.655

Hepion Pharmaceuticals, Inc (HEPA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1583771/000155837020007863/0001558370-20-007863-index.htm
2019-02-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1583771/000000000019001894/0000000000-19-001894-index.htm
2019-02-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1583771/000000000019001897/0000000000-19-001897-index.htm
2019-05-28UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1583771/000000000019008945/0000000000-19-008945-index.htm
2019-05-20S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1583771/000104746919003204/0001047469-19-003204-index.htm
2019-06-05S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1583771/000104746919003459/0001047469-19-003459-index.htm
2019-06-12S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1583771/000104746919003570/0001047469-19-003570-index.htm
2019-06-19424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1583771/000104746919003729/0001047469-19-003729-index.htm
2018-10-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465918062761/0001104659-18-062761-index.htm
2018-10-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465918063055/0001104659-18-063055-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465918067948/0001104659-18-067948-index.htm
2018-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1583771/000110465918068499/0001104659-18-068499-index.htm
2018-11-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1583771/000110465918070593/0001104659-18-070593-index.htm
2018-11-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1583771/000110465918070697/0001104659-18-070697-index.htm
2018-12-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465918073108/0001104659-18-073108-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919000174/0001104659-19-000174-index.htm
2019-01-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919001975/0001104659-19-001975-index.htm
2019-01-29S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1583771/000110465919004129/0001104659-19-004129-index.htm
2019-02-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1583771/000110465919006106/0001104659-19-006106-index.htm
2019-02-13S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1583771/000110465919007752/0001104659-19-007752-index.htm
2019-02-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1583771/000110465919007753/0001104659-19-007753-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919012470/0001104659-19-012470-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1583771/000110465919014652/0001104659-19-014652-index.htm
2019-03-18PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919015647/0001104659-19-015647-index.htm
2019-03-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919016027/0001104659-19-016027-index.htm
2019-03-27DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919017816/0001104659-19-017816-index.htm
2019-04-02SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919019188/0001104659-19-019188-index.htm
2019-04-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919019189/0001104659-19-019189-index.htm
2019-04-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919019408/0001104659-19-019408-index.htm
2019-04-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919020014/0001104659-19-020014-index.htm
2019-04-18S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1583771/000110465919022389/0001104659-19-022389-index.htm
2019-04-22CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1583771/000110465919022894/0001104659-19-022894-index.htm
2019-04-26424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1583771/000110465919024064/0001104659-19-024064-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919026521/0001104659-19-026521-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919027086/0001104659-19-027086-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919027832/0001104659-19-027832-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1583771/000110465919029790/0001104659-19-029790-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919032979/0001104659-19-032979-index.htm
2019-06-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1583771/000110465919033936/0001104659-19-033936-index.htm
2019-06-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1583771/000110465919033993/0001104659-19-033993-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919034222/0001104659-19-034222-index.htm
2019-06-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919034945/0001104659-19-034945-index.htm
2019-06-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1583771/000110465919035014/0001104659-19-035014-index.htm
2019-06-13RWRegistration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919035316/0001104659-19-035316-index.htm
2019-06-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1583771/000110465919035346/0001104659-19-035346-index.htm
2019-06-13RW WDWithdrawal of Registration Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919035368/0001104659-19-035368-index.htm
2019-06-14CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1583771/000110465919035595/0001104659-19-035595-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919035846/0001104659-19-035846-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919036721/0001104659-19-036721-index.htm
2019-06-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919037772/0001104659-19-037772-index.htm
2019-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919041380/0001104659-19-041380-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919041843/0001104659-19-041843-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919041844/0001104659-19-041844-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919041845/0001104659-19-041845-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919041847/0001104659-19-041847-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919041849/0001104659-19-041849-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919041850/0001104659-19-041850-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919041851/0001104659-19-041851-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919042663/0001104659-19-042663-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919042855/0001104659-19-042855-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919044473/0001104659-19-044473-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919045808/0001104659-19-045808-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1583771/000110465919045967/0001104659-19-045967-index.htm
2019-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919048456/0001104659-19-048456-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919048627/0001104659-19-048627-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919052985/0001104659-19-052985-index.htm
2019-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919053382/0001104659-19-053382-index.htm
2019-10-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919053658/0001104659-19-053658-index.htm
2019-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919054409/0001104659-19-054409-index.htm
2019-10-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1583771/000110465919055285/0001104659-19-055285-index.htm
2019-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919055831/0001104659-19-055831-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919060965/0001104659-19-060965-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919061252/0001104659-19-061252-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1583771/000110465919064342/0001104659-19-064342-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919065988/0001104659-19-065988-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919069534/0001104659-19-069534-index.htm
2019-12-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919069650/0001104659-19-069650-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465919071787/0001104659-19-071787-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920001530/0001104659-20-001530-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920002344/0001104659-20-002344-index.htm
2020-01-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920007676/0001104659-20-007676-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920012568/0001104659-20-012568-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920013407/0001104659-20-013407-index.htm
2020-02-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1583771/000110465920018093/0001104659-20-018093-index.htm
2020-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920019281/0001104659-20-019281-index.htm
2020-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920019329/0001104659-20-019329-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920023108/0001104659-20-023108-index.htm
2020-03-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920031925/0001104659-20-031925-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920032197/0001104659-20-032197-index.htm
2020-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1583771/000110465920039007/0001104659-20-039007-index.htm
2020-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920039453/0001104659-20-039453-index.htm
2020-03-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920040351/0001104659-20-040351-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920044168/0001104659-20-044168-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920044169/0001104659-20-044169-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920044170/0001104659-20-044170-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920044171/0001104659-20-044171-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920044173/0001104659-20-044173-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920044174/0001104659-20-044174-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920044175/0001104659-20-044175-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920048184/0001104659-20-048184-index.htm
2020-05-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1583771/000110465920061587/0001104659-20-061587-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920061607/0001104659-20-061607-index.htm
2020-05-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920063482/0001104659-20-063482-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920063929/0001104659-20-063929-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920064298/0001104659-20-064298-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920072061/0001104659-20-072061-index.htm
2020-06-12DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920072949/0001104659-20-072949-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920073220/0001104659-20-073220-index.htm
2020-06-1510-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1583771/000110465920073279/0001104659-20-073279-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920075664/0001104659-20-075664-index.htm
2020-06-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920076747/0001104659-20-076747-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920076967/0001104659-20-076967-index.htm
2020-06-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920078110/0001104659-20-078110-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920081577/0001104659-20-081577-index.htm
2020-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920088432/0001104659-20-088432-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920090611/0001104659-20-090611-index.htm
2020-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920093579/0001104659-20-093579-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920097591/0001104659-20-097591-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920097592/0001104659-20-097592-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920097593/0001104659-20-097593-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920097596/0001104659-20-097596-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920097598/0001104659-20-097598-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920097599/0001104659-20-097599-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920097600/0001104659-20-097600-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1583771/000110465920097602/0001104659-20-097602-index.htm
2020-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920099208/0001104659-20-099208-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920101285/0001104659-20-101285-index.htm
2020-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920106030/0001104659-20-106030-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920109531/0001104659-20-109531-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920111073/0001104659-20-111073-index.htm
2020-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920112001/0001104659-20-112001-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000110465920118410/0001104659-20-118410-index.htm
2020-10-29S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1583771/000110465920119514/0001104659-20-119514-index.htm
2019-06-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1583771/000119312519185110/0001193125-19-185110-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1583771/000119312520038287/0001193125-20-038287-index.htm
2020-02-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1583771/000139382520000049/0001393825-20-000049-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000141057819000430/0001410578-19-000430-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1583771/000141057819000450/0001410578-19-000450-index.htm
2020-06-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1583771/000155837020007863/0001558370-20-007863-index.htm
2020-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1583771/000155837020010449/0001558370-20-010449-index.htm
2019-03-18SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1583771/000156761919007023/0001567619-19-007023-index.htm
2019-03-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1583771/000177063219000002/0001770632-19-000002-index.htm
2019-02-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1583771/999999999519000300/9999999995-19-000300-index.htm
2019-04-24EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1583771/999999999519000851/9999999995-19-000851-index.htm
2019-06-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1583771/999999999519001360/9999999995-19-001360-index.htm